Cbl-b is a negative regulator of inflammatory cytokines produced by IgE-activated mast cells

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 5980-5989

  Gustin, Sonja E ^a,b   Thien, Christine B F ^a   Langdon, Wallace Y ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CBL PROTEIN; CELL SURFACE RECEPTOR; I KAPPA B KINASE; IMMUNOGLOBULIN E; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN B CBL; PROTEIN KINASE B; PROTEIN KINASE LYN; PROTEIN KINASE SYK; TUMOR NECROSIS FACTOR ALPHA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW CELL; CELL ACTIVATION; CELL GROWTH; CELL STRAIN; CELL TRANSPORT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME SUBSTRATE; HEMATOPOIETIC CELL; INFLAMMATION; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RECEPTOR AFFINITY; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; WILD TYPE;

EID: 33750327245     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.5980     Document Type: Article

References (56)

1. Kawakami, T., and S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2: 773-786.
2. Galli, S. J., J. Kalesnikoff, M. A. Grimbaldeston, A. M. Piliponsky, W. C.M.M., and M. Tsai. 2005. Mast cells as tunable effector and immunoregultory cells: recent advances. Annu. Rev. Immunol. 23: 749-786.
3. Gilfillan, A. M., and C. Tkaczyk. 2006. Integrated signalling pathways for mast cell activation. Nat. Rev. Immunol. 6: 218-230.
4. Saitoh, S., R. Arudchandran, T. S. Manetz, W. Zhang, C. L. Sommers, P. E. Love, J. Rivera, and L. E. Samelson. 2000. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12: 525-535.
5. Hendricks-Taylor, L. R., D. G. Motto, J. Zhan, R. P. Siraganian, and G. A. Koretzky. 1997. SLP-76 is a substrate of the high affinity IgE receptor-stimulated protein tyrosine kinases in rat basophilic leukemia cells. J. Biol. Chem. 272: 1363-1367.
6. Volná, P., P. Lebduska, L. Dráberová, S. Símová, P. Heneberg, M. Boubelík, V. Bugajev, B. Malissen, B. S. Wilson, V. Horejsí, et al. 2004. Negative regulation of mast cell signaling and function by the adaptor LAB/NTAL. J. Exp. Med. 200: 1001-1013.
7. Zhu, M., Y. Liu, S. Koonpaew, O. Granillo, and W. Zhang. 2004. Positive and negative regulation of FcεRI-mediated signaling by the adaptor protien LAB/NTAL. J. Exp. Med. 200: 991-1000.
8. Manetz, T. S., C. Gonzalez-Espinosa, R. Arudchandran, V. Xirasagar, V. Tybulewicz, and J. Rivera. 2001. Vav1 regulates phospholipase Cγ and calcium responses in mast cells. Mol. Cell. Biol. 21: 3763-3774.
9. Gu, H., K. Salto, L. D. Klaman, J. Shen, T. Fleming, Y. P. Wang, J. C. Pratt, G. Lin, B. Lim, J.-P. Kinet, and B. G. Neel. 2001. Essential role for Gab2 in the allergic response. Nature 412: 186-190.
10. Parravicini, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L. E. Samelson, J. J. O'Shea, and J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3: 741-748.
11. Galli, S. J. 1993. New concepts about the mast cell. N. Engl. J. Med. 328: 257-265.
12. Oliver, J. M., D. L. Burg, B. S. Wilson, J. McLaughlin, and R. L. Geahlen. 1994. Inhibition of mast cell FcεRI-mediated signaling and effector function by the Syk-selective inhibitor, piceatannol. J. Biol. Chem. 269: 15790-15796.
13. Costello, P. S., M. Turner, A. E. Walters, C. N. Cunningham, P. H. Bauer, J. Downward, and V. L. Tybulewicz. 1996. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene 13: 2596-2605.
14. Zhang, J., E. H. Berenstein, R. L. Evans, and R. P. Siraganian. 1996. Transfection of syk tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J. Exp. Med. 184: 71-79.
15. Lafont, F., and K. Simons. 2001. Raft-partitioning of the ubiquitin ligases Cbl and Nedd4 upon IgE-triggered cell signaling. Proc. Natl. Acad. Sci. USA 98: 3180-3184.
16. Paolini, R., R. Molfetta, L. O. Beitz, J. Zhang, A. M. Scharenberg, M. Piccoli, L. Frati, R. Siraganian, and A. Santoni. 2002. Activation of Syk tyrosine kinase is required for c-Cbl-mediated ubiquitination of FceRI and Syk in RBL cells. J. Biol. Chem. 277: 36940-36947.
17. Rao, N., A. K. Ghosh, S. Ota, P. Zhou, A. L. Reddi, K. Hakezi, B. K. Druker, J. Wu, and H. Band. 2001. The non-receptor tyrosine kinase Syk is a target of Cbl-mediated ubiquitylation upon B-cell receptor stimulation. EMBO J. 20: 7085-7095.
18. Joazeiro, C. A. P., S. S. Wing, H.-K. Huang, J. D. Leverson, T. Hunter, and Y.-C. Liu. 1999. The tyrosine kinase negative regulator c-Cbl as a RING-type, E2-dependent ubiquitin-protein ligase. Science 286: 309-312.
19. Levkowitz, G., H. Waterman, S. A. Ettenberg, M. Katz, S. Lavi, K. Iwai, Y. Reiss, A. Ciechanover, S. Lipkowitz, and Y. Yarden. 1999. Ubiquitin ligase activity and tyrosine phosphorylation underlie suppression of growth factor signaling by C-Cbl/Sli-1. Mol. Cell 4: 1029-1040.
20. Thien, C. B. F., and W. Y. Langdon. 2005. c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem. J. 391: 153-166.
21. Schmidt, M. H. H., and I. Dikic. 2005. The Cbl interactome and its function. Nat. Rev. Mol. Cell Biol. 6: 907-918.
22. Duan, L., A. L. Reddi, A. Ghosh, M. Dimri, and H. Band. 2004. The Cbl family and other ubiquitin ligases: destructive forces in control of antigen receptor signaling. Immunity 21: 7-17.
23. Zhang, J., Y. J. Chiang, R. J. Hodes, and R. P. Siraganian. 2004. Inactivation of c-Cbl or Cbl-b differentially affects signaling from the high affinity IgE receptor. J. Immunol. 173: 1811-1818.
24. Qu, X., K. Sada, S. Kyo, K. Maeno, S. M. S. Miah, and H. Yamamura. 2004. Negative regulation of FcεRI-mediated mast cell activation by ubiquitin-protein ligase Cbl-b. Blood 103: 1779-1786.
25. Qu, X., S. M. S. Miah, T. Hatani, M. Okazaki, N. Hori-Tamura, H. Yamamura, H. Hotta, and K. Sada. 2005. Selective inhibition of FcεRI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type I diabetes mellitus. J. Biochem. 137: 711-720.
26. Ota, Y., and L. E. Samelson. 1997. The product of the proto-oncogene c-Cbl-a negative regulator of the Syk tyrosine kinase. Science 276: 418-420.
27. Naramura, M., I. K. Jang, H. Kole, F. Huang, D. Haines, and H. Gu. 2002. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nat. Immunol. 3: 1192-1199.
28. Wilson, B. S., J. R. Pfeiffer, and J. M. Oliver. 2000. Observing FcεRI signaling from the inside of the mast cell membrane. J. Cell Biol. 149: 1131-1142.
29. Murphy, M. A., R. G. Schnall, D. J. Venter, L. Barnett, I. Bertoncello, C. B. F. Thien, W. Y. Langdon, and D. D. L. Bowtell. 1998. Tissue hyperplasia and enhanced T cell signalling via ZAP-70 in c-Cbl deficient mice. Mol. Cell. Biol. 18: 4872-4882.
30. Bachmaier, K., C. Krawczyk, I. Kozieradzki, Y.-Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403: 211-216.
31. Thien, C. B. F., D. D. L. Bowtell, and W. Y. Langdon. 1999. Perturbed regulation of ZAP-70 and sustained tyrosine phosphorylation of LAT and SLP-76 in c-Cbl-deficient thymocytes. J. Immunol. 162: 7133-7139.
32. Hunter, S., E. A. Burton, S. C. Wu, and S. M. Anderson. 1999. Fyn associates with Cbl and phosphorylates tyrosine 731 in Cbl, a binding site for phosphatidylinositol 3-kinase. J. Biol. Chem. 274: 2097-2106.
33. Ueno, H., K. Sasaki, H. Honda, T. Nakamoto, K. Miyagawa, K. Mitani, Y. Yazaki, and H. Hirai. 1998. c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and survival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3′-kinase pathway. Blood 91: 46-53.
34. Cbl phosphorylation in human air-way smooth muscle cells. J. Immunol. 166: 155-161.
35. Arron, J. R., M. Vologodskaia, B. R. Wong, M. Naramura, N. Kim, H. Gu, and Y. Choi. 2001. A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (TRANCE) and CD40L-mediated Akt activation. J. Biol. Chem. 276: 30011-30017.
36. Thien, C. B. F., F. D. Blystad, Y. Zhan, A. M. Lew, V. Voigt, C. E. Andoniou, and W. Y. Langdon. 2005. Loss of c-Cbl RING finger function results in high-intensity signaling and thymic deletion. EMBO J. 24: 3807-3819.
37. Waterman, H., G. Levkowitz, I. Alroy, and Y. Yarden. 1999. The RING finger of c-Cbl mediates desensitization of the epidermal growth factor. J. Biol. Chem. 274: 22151-22154.
38. Soubeyran, P., K. Kowanetz, I. Szymkiewicz, W. Y. Langdon, and I. Dikic. 2002. Cbl-CIN85-endophilin complex mediates ligand-induced downregulation of EGF receptors. Nature 416: 183-187.
39. Petrelli, A., G. F. Gilestro, S. Lanzardo, P. M. Comoglio, N. Migone, and S. Giordano. 2002. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 416: 187-190.
40. Huang, F., and A. Sorkin. 2005. Growth factor receptor binding protein 2-mediated recruitment of the RING domain of Cbl to the epidermal growth factor receptor is essential and sufficiant to support receptor endocytosis. Mol. Biol. Cell 16: 1268-1281.
41. Molfetta, R., F. Belleudi, G. Peruzzi, S. Morrone, L. Leone, I. Dikic, M. Piccoli, L. Frati, M. R. Torrisi, A. Santoni, and R. Paolini. 2005. CIN85 regulates the ligand-dependent endocytosis of the IgE receptor: a new molecular mechansims to dampen mast cell function. J. Immunol. 175: 4208-4216.
42. Naramura, M., H. K. Kole, R.-J. Hu, and H. Gu. 1998. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl. Acad. Sci. USA 95: 15547-15552.
43. Pelletier, C., N. Varin-Blank, J. Rivera, B. Iannascoli, F. Marchand, B. David, A. Weyer, and U. Blank. 1998. FcεRI-mediated induction of TNFα gene expression in the RBL-2H3 mast cell line: regulation of a novel NF-κB-like nuclear binding complex. J. Immunol. 161: 4768-4776.
44. Ping, D., G. Boekhoudt, F. Zhang, A. Morris, S. Philipsen, S. T. Warren, and J. M. Boss. 2000. Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor. J. Biol. Chem. 275: 1708-1714.
45. You, M., L. M. Flick, D. Yu, and G.-S. Feng. 2001. Modulation of the nuclear factor κB pathway by Shp-2 tyrosine phosphatase in mediating the induction of interleukin (IL)-6 by IL-1 or tumor necrosis factor. J. Exp. Med. 193: 101-109.
46. Moffatt, S., N. Tanaka, K. Tada, M. Nose, M. Nakamura, O. Muraoka, T. Hirano, and K. Sugamura. 1996. A cytotoxic nonstructural protein NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol. 70: 8485-8491.
47. Boekhoudt, G. H., Z. Guo, G. W. Beresford, and J. M. Boss. 2003. Communication between NF-κB and Sp1 controls histone acetylation within the proximal promoter of the monocyte chemoattractant protein 1 gene. J. Immunol. 170: 4139-4147.
48. Jeong, H. J., H. N. Koo, H. J. Na, M. S. Kim, S. H. Hong, J. W. Eom, K. S. Kim, T. Y. Shin, and H. M. Kim. 2002. Inhibition of TNF-α and IL-6 production by Aucubin through blockade of NF-κB activation of RBL-2H3 mast cells. Cytokine 18: 252-259.
49. Peng, Y., M. R. Power, B. Li, and T. J. Lin. 2005. Inhibition of IKK down-regulates antigen + IgE-induced TNF production by mast cells: a role for the IIK-IκB-κB pathway in IgE-dependent mast cell activation. J. Leukocyte Biol. 77: 975-983.
50. Klemm, S., J. Gutermuth, L. Hultner, T. Sparwasser, H. Behrendt, J. Peschel, T. W. Mak, T. Jakob, and J. Ruland. 2006. The Bcl10-Malt1 complex segregates FcεR-mediated nuclear factor κB activation and cytokine production from mast cell degranulation. J. Exp. Med. 203: 337-347.
51. Shao, Y., C. Yang, C. Elly, and Y.-C. Liu. 2004. Differential regulation of the B cell receptor-mediated signaling by the E3 ubiquitin ligase Cbl. J. Biol. Chem. 279: 43546-43653.
52. Andoniou, C. E., N. L. Lill, C. B. Thien, M. L. Lupher, Jr., S. Ota, D. D. L. Bowtell, R. M. Scaife, W. Y. Langdon, and H. Band. 2000. The Cbl proto-oncogene product negatively regulates the Src-family tyrosine kinase Fyn by enhancing its degradation. Mol. Cell. Biol. 20: 851-867.
53. Thien, C. B. F., R. M. Scaife, J. M. Papadimitriou, M. A. Murphy, D. D. L. Bowtell, and W. Y. Langdon. 2003. A mouse with a loss-of-function mutation in the c-Cbl TKB domain shows perturbed thymocyte signaling without enhancing the activity of the ZAP-70 tyrosine kinase. J. Exp. Med. 197: 503-513.
54. Luster, A. D., and M. E. Rothenberg. 1997. Role of the monocyte chemoattractant protein and eotaxin subfamily of chemokines in allergic inflammation. J. Leukocyte Biol. 62: 620-633.
55. Gordon, J. R. 2000. Monocyte chemoattractant peptide-1 expression during cutaneous allegic reactions in mice is mast cell dependent and largely mediates the monocyte recruitment response. J. Allergy Clin. Immunol. 106: 110-116.
56. Kassenbrock, K. C., and S. M. Anderson. 2004. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations. J. Biol. Chem. 279: 28017-28027.